<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.32111.009</object-id><label>Table 1.</label><caption><title>Anthropometric, clinical and metabolic characteristics of obese females stratified into a upper tertile and lower two tertiles based on adipose tissue mitochondrial CoQ content (CoQ<sub>high</sub> vs CoQ<sub>low</sub>).</title><p>All p values calculated by Mann Whitney test, p&gt;0.05 in bold.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristics</th><th>CoQ<sub>high</sub> (n&#160;=&#160;11)</th><th>CoQ<sub>low</sub> (n&#160;=&#160;22)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>Age, y</td><td>53&#160;&#177;&#160;11</td><td>51&#160;&#177;&#160;13</td><td>0.70</td></tr><tr><td>BMI, kg/m<sup>2</sup></td><td>36.6&#160;&#177;&#160;4.2</td><td>36.9&#160;&#177;&#160;5.1</td><td>0.92</td></tr><tr><td>Subcutaneous fat, cm<sup>2</sup> <italic>a</italic></td><td>588&#160;&#177;&#160;132</td><td>546&#160;&#177;&#160;114</td><td>0.33</td></tr><tr><td>Visceral fat, cm<sup>2</sup> <italic>a</italic></td><td>210&#160;&#177;&#160;37</td><td>264&#160;&#177;&#160;74</td><td>0.07</td></tr><tr><td>Liver fat, % <italic>a</italic></td><td>6.8&#160;&#177;&#160;4.5</td><td>13.6&#160;&#177;&#160;10.3</td><td>0.06</td></tr><tr><td>Mean adipocyte size, &#956;m <italic>b</italic></td><td>71.3&#160;&#177;&#160;8.9</td><td>72.6&#160;&#177;&#160;9.0</td><td>0.90</td></tr><tr><td>Total cholesterol, mmol/L</td><td>5.0&#160;&#177;&#160;0.8</td><td>4.8&#160;&#177;&#160;0.7</td><td>0.87</td></tr><tr><td>LDL cholesterol, mmol/L</td><td>3.0&#160;&#177;&#160;0.8</td><td>2.9&#160;&#177;&#160;0.6</td><td>0.89</td></tr><tr><td>HDL cholesterol, mmol/L</td><td>1.5&#160;&#177;&#160;0.2</td><td>1.4&#160;&#177;&#160;0.3</td><td>0.19</td></tr><tr><td>Triacylglycerides, mmol/L</td><td>0.8&#160;&#177;&#160;0.3</td><td>1.0&#160;&#177;&#160;0.4</td><td>0.15</td></tr><tr><td>Fasting insulin, mU/L</td><td>14.2&#160;&#177;&#160;4.9</td><td>16.0&#160;&#177;&#160;7.4</td><td>0.71</td></tr><tr><td>Fasting NEFA, mmol/L</td><td>0.46&#160;&#177;&#160;0.14</td><td>0.43&#160;&#177;&#160;0.13</td><td>0.63</td></tr><tr><td>NEFA during low dose insulin infusion, mmol/L</td><td>0.03&#160;&#177;&#160;0.02</td><td>0.06&#160;&#177;&#160;0.03</td><td><bold>0.03</bold></td></tr><tr><td>NEFA suppression during low dose insulin infusion, %</td><td>92.1&#160;&#177;&#160;4.5</td><td>86.5&#160;&#177;&#160;6.9</td><td><bold>0.01</bold></td></tr><tr><td>Glucose infusion rate during high dose insulin infusion, &#956;mol/kg fat free mass/min</td><td>117.8&#160;&#177;&#160;26.6</td><td>98.5&#160;&#177;&#160;29.4</td><td><bold>0.02</bold></td></tr><tr><td>Endogenous glucose production suppression during low-dose insulin infusion, %</td><td>73.6&#160;&#177;&#160;12.1</td><td>60.5&#160;&#177;&#160;15.7</td><td><bold>0.03</bold></td></tr><tr><td>HOMA-IR score</td><td>2.9&#160;&#177;&#160;1.1</td><td>3.5&#160;&#177;&#160;1.7</td><td>0.40</td></tr></tbody></table><table-wrap-foot><fn><p><italic>a</italic> &#8211;CoQ<sub>high</sub>n&#160;=&#160;10, CoQ<sub>low</sub>n&#160;=&#160;22.</p><p><italic>b</italic> - CoQ<sub>high</sub>n&#160;=&#160;9, CoQ<sub>low</sub>n&#160;=&#160;18.</p></fn></table-wrap-foot></table-wrap>